Neuroprotection with erythropoietin in preterm and/or low birth weight infants

Journal of Clinical Neuroscience

Volumn 21, Issue 8, 2014, Pages 1283-1287

  Zhang, Jie ^a   Wang, Qiuxia ^a   Xiang, Hong ^a   Xin, Yue ^a   Chang, Ming ^a   Lu, Hongyan ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

Brain injury; Erythropoietin; Low birth weight infants; Neonates; Neurodevelopmental outcome

Indexed keywords

ERYTHROPOIETIN; PLACEBO; NEUROPROTECTIVE AGENT;

BRAIN DISEASE; BRAIN HEMORRHAGE; CEREBRAL PALSY; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HEARING DISORDER; HUMAN; INFANT; LOW BIRTH WEIGHT; META ANALYSIS; MORBIDITY; MORTALITY; MULTICENTER STUDY (TOPIC); NECROTIZING ENTEROCOLITIS; NEUROPROTECTION; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW; VISUAL DISORDER; BRAIN DISEASES; DEVELOPMENTAL DISABILITIES; NEWBORN;

BRAIN DISEASES; DEVELOPMENTAL DISABILITIES; ERYTHROPOIETIN; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; NEUROPROTECTIVE AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84904260040     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2013.10.040     Document Type: Review

References (36)

1. J.E. Lawn, S.N. Cousens, and G.L. Darmstadt et al. 1 year after the Lancet Neonatal Survival Series - was the call for action heard? Lancet 367 2006 1541 1547
2. R. Goldenberg, J. Culhane, and J. Iams et al. Epidemiology and causes of preterm birth Lancet 371 2008 75
3. L.J. Woodward, S. Moor, and K.M. Hood et al. Very preterm children show impairments across multiple neurodevelopmental domains by age 4 years Arch Dis Child-Fetal Neonatal Ed 94 2009 339 344
4. N. Davis, G. Ford, and P. Anderson et al. Developmental coordination disorder at 8 years of age in a regional cohort of extremely-low-birthweight or very preterm infants Dev Med Child Neurol 49 2007 325 330
5. D. Wilson-Costello, H. Friedman, and N. Minich et al. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s Pediatrics 115 2005 997 1003
6. B.R. Vohr, L.L. Wright, and A.M. Dusick et al. Center differences and outcomes of extremely low birth weight infants Pediatrics 113 2004 781 789
7. P. Ghezzi, M. Bernaudin, and R. Bianchi et al. Erythropoietin: not just about erythropoiesis Lancet 375 2010 2142
8. A. Ohlsson, and S.M. Aher Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants Cochrane Database Syst Rev 19 2006 CD004863
9. R.J. McPherson Can erythropoietin improve developmental outcomes for preterm infants? Pediatrics 124 2009 e805 e806
10. N.R. Newton, C.H. Leonard, and R.E. Piecuch et al. Neurodevelopmental outcome of prematurely born children treated with recombinant human erythropoietin in infancy J Perinatol 19 1999 403 406
11. R.K. Ohls, R.A. Ehrenkranz, and A. Das et al. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron Pediatrics 114 2004 1287 1291
12. G.R. Alexander, J.H. Himes, and R.B. Kaufman et al. A United States national reference for fetal growth Obstet Gynecol 87 1996 163 168
13. R. Bierer, M.C. Peceny, and C.H. Hartenberger et al. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants Pediatrics 118 2006 e635 e640
14. J.C. Fauchere, C. Dame, and R. Vonthein et al. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants Pediatrics 122 2008 375 382
15. J.S. He, Z.L. Huang, and H. Yang et al. Early use of recombinant human erythropoietin promotes neurobehavioral development in preterm infants Zhongguo Dang Dai Er Ke Za Zhi 10 2008 586 588
16. S.E. Juul, R.J. McPherson, and L.A. Bauer et al. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety Pediatrics 122 Aug 2008 383 391
17. A.P. Neubauer, W. Voss, and M. Wachtendorf et al. Erythropoietin improves neurodevelopmental outcome of extremely preterm infants Ann Neurol 67 2010 657 666
18. S. Jones, A. D'Andrea, and L. Haines et al. Human erythropoietin receptor: cloning, expression, and biologic characterization Blood 76 1990 31 35
19. P.E. Sanchez, F.P. Navarro, and R.P. Fares et al. Erythropoietin receptor expression is concordant with erythropoietin but not with common β chain expression in the rat brain throughout the life span J Comp Neurol 514 2009 403 414
20. Y. Wang, W. Liu, and Y. Cao et al. Focused Conference Group: P01-clinical pharmacology in the emerging countries study on protection effect of erythropoietin on newborn rats with hypoxic-ischemic brain damage Basic Clin Pharmacol Toxicol 107 2010 651
21. A. Kumral, K. Tugyan, and S. Gonenc et al. Protective effects of erythropoietin against ethanol-induced apoptotic neurodegenaration and oxidative stress in the developing C57BL/6 mouse brain Dev Brain Res 160 2005 146 156
22. S.E. Juul, R.P. Beyer, and T.K. Bammler et al. Microarray analysis of high-dose recombinant erythropoietin treatment of unilateral brain injury in neonatal mouse hippocampus Pediatr Res 65 2009 485 492
23. O. Brissaud, F. Villega, and J.P. Konsman et al. Short-term effect of erythropoietin on brain lesions and aquaporin-4 expression in a hypoxic-ischemic neonatal rat model assessed by magnetic resonance diffusion weighted imaging and immunohistochemistry Pediatr Res 68 2010 123 127
24. M. Mazur, R.H. Miller, and S. Robinson Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injury: laboratory investigation J Neurosurg Pediatr 6 2010 206
25. X. Wang, C. Zhu, and X. Wang et al. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin J Neurochem 91 2004 900 910
26. T. Xiong, Y. Qu, and D. Mu et al. Erythropoietin for neonatal brain injury: opportunity and challenge Int J Dev Neurosci 29 2011 583 591
27. M. Buemi, E. Cavallaro, and F. Floccari et al. The pleiotropic effects of erythropoietin in the central nervous system J Neuropathol Exp Neurol 62 2003 228 236
28. S. Juul Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage Acta Paediatr 91 2002 36 42
29. G. Grasso, A. Sfacteria, and A. Cerami et al. Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go? Neuroscientist 10 2004 93 98
30. M.A. Mikati, J.A. Hokayem, and M.E. Sabban Effects of a single dose of erythropoietin on subsequent seizure susceptibility in rats exposed to acute hypoxia at P10 Epilepsia 48 2007 175 181
31. F.F. Gonzalez, R. Abel, and C.R. Almli et al. Erythropoietin sustains cognitive function and brain volume after neonatal stroke Dev Neurosci 31 2009 403 411
32. R.J. McPherson, E.J. Demers, and S.E. Juul Safety of high-dose recombinant erythropoietin in a neonatal rat model Neonatology 91 2007 36 43
33. C.M. Chen, M.J. Jeng, and S.Y. Chiu et al. Conditions associated with hypertension in a high-risk premature infant J Chin Med Assoc 71 2008 485 490
34. J. Shibata, J. Hasegawa, and H.J. Siemens et al. Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis Blood 101 2003 4416 4422
35. N. Haiden, F. Cardona, and J. Schwindt et al. Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity Thromb Haemost 93 2005 118 123
36. M. Zaffanello, M. Franchini, and S. Rugolotto Recombinant human erythropoietin might induce strawberry haemangiomas in very-low-birthweight preterm infants Acta Paediatr 92 2003 1353 1354